The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-1H-indazole-3-carboxamide
ID: ALA1078238
Cas Number: 23765-17-5
PubChem CID: 46882662
Max Phase: Preclinical
Molecular Formula: C14H10ClN3O
Molecular Weight: 271.71
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1n[nH]c2ccccc12
Standard InChI: InChI=1S/C14H10ClN3O/c15-10-6-2-4-8-12(10)16-14(19)13-9-5-1-3-7-11(9)17-18-13/h1-8H,(H,16,19)(H,17,18)
Standard InChI Key: OOFRWLRRQQMZSP-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
11.9892 -7.9493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9881 -8.7766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7028 -9.1894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7010 -7.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4164 -7.9456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4212 -8.7721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2086 -9.0228 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6905 -8.3514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2008 -7.6858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2178 -6.8628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9396 -6.4634 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.5111 -6.4374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5261 -5.6126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2524 -5.2166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2678 -4.3925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5627 -3.9735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8362 -4.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8244 -5.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1039 -5.5945 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 1 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.71 | Molecular Weight (Monoisotopic): 271.0512 | AlogP: 3.47 | #Rotatable Bonds: 2 |
Polar Surface Area: 57.78 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.83 | CX Basic pKa: ┄ | CX LogP: 3.38 | CX LogD: 3.38 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.75 | Np Likeness Score: -2.05 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |